5.13 Keratitis, Microbial, Fungal

Date of last review:

10/04/2026

Date of next review:

10/04/2028 

Date of publication:

20/04/2026


Differential diagnosis (1)

  • Bacterial Keratitis

  • Corneal inflammatory non-infectious lesions (contact lens related or marginal keratitis)

  • Peripheral, small (0.5-1.5 mm) with less anterior chamber response

  • Macro corneal erosion in vernal keratoconjunctivitis

  • Acanthamoeba keratitis (AK)

  • Suspect AK if multiple epithelial or subepithelial infiltrates, perineural infiltrates or dendritiform epithelial lesions

  • Herpes Simplex keratitis


Possible management by optometrist

Advice

  • Immediately stop contact lens wear (1)

  • Advise patients to retain lenses and cases for possible microbiological culture (1)

  • Maintain a low threshold for AK suspicion if recent contact with water (e.g. swimming) (7)

Treatment (1)

  • None – same day emergency referral


Typical adult dosage/duration

(Blue text = IP, black text = non-IP)

  • Not applicable for this condition

Regimens should be adjusted according to severity and patient factors (e.g. age, weight, pregnancy, renal function). Prescribing should follow local formulary and national guidance where available (7).

In cases of known sensitivities, please consult local formularies for alternative options (7).


Further management options (1)

  • Emergency referral (same day)


Possible management in secondary care or local/community pathways where available (1)

  • See further management options

  • Corneal scraping for culture and antibiotic sensitivity, due to evolving pathogen profiles and resistance

  • Polymerase chain reaction (PCR) testing where available

  • Possible hospital admission for poor compliance, overnight therapy, or severe lesions (axial, ≥6 mm, or ≥50% stromal thinning)

  • Cycloplegics for comfort

  • IOP lowering therapy if required

  • Topical steroids only once infection is controlled (evidence remains limited)

  • Corneal crosslinking may be considered in selected cases

  • Amphotericin B 0.15% for yeast infections (e.g. Candida)

  • Usually requires combined topical (natamycin 5%, econazole 1%, or voriconazole 1%) and oral therapy (e.g. oral voriconazole)


College of Optometrists Clinical Management Guideline (1) 

Microbial keratitis (bacterial, fungal) - College of Optometrists

*With special thanks to The College of Optometrists for providing the evidence framework for diagnosis and management from the Clinical Management Guidelines (CMGs) for this condition. All references to the College/CMGs are included where appropriate and form the basis of the Community Eyecare Guidelines.


Guidance is informed by the following sources 

  1. College of Optometrists Clinical Management Guidelines Clinical Management Guidelines - College of Optometrists

  2. Advisory alignment with the College of Optometrists Formulary Optometrists' Formulary - College of Optometrists

  3. Advisory alignment with the BNF BNF (British National Formulary) | NICE

  4. Advisory alignment with the Summary Product Characteristics taken from the EMC Home - electronic medicines compendium (emc)

  5. Advisory alignment with Scottish Health Board formularies (where a clear majority is present) *

  6. Advisory alignment with expert consensus (CEGG), informed by sources 2-5 above

  7. Advisory alignment with expert consensus (CEGG) 

  8. “Annex C of the Statement” https://www.eyes.nhs.scot/for-professionals/legislation/

* Scottish formularies should be available within the Prescribing section of your Health Board pages on the eyes.nhs.scot website. If unavailable, contact your local Health Board for further information; Health Boards landing page

 


If you have a query relating to this page, please email NSS.ComEyecareGuidelineGroup@nhs.scot